NMRA — NEUMORA THERAPEUTICS INC.

Ownership history in EntryPoint Capital, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which EntryPoint Capital, LLC reported a position in NEUMORA THERAPEUTICS INC. (NMRA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.1% (2025 Q4)
Avg. % of fund
0.08%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 145,385 +132,623 +1039.2% 0.10% $260K $1.79
2024 Q4 INITIATED 12,762 — — 0.06% $135K $10.60
% of Fund (quarterly)    NMRA price (monthly, adj. close)

Other funds also holding NMRA

As of 2025 Q4 — sorted by position size

MIC Capital Management UK LLP 3Y 1.81% JOHNSON & JOHNSON 3Y 0.6% Siren, L.L.C. 0.34% Ikarian Capital, LLC 3Y 0.18% Addis & Hill, Inc 0.18% Henson-Edgewater Management, LLC 0.18% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.09% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.08% ICONIQ Capital, LLC 3Y 7Y 0.07% SkyOak Wealth, LLC 3Y 0.03%
← Back to EntryPoint Capital, LLC Holdings